EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Predicting Clinically Significant Portal Hypertension in MASLD Using Routine Ultrasound and Clinical Data: A Retrospective Cohort Study

Nebyu Yonas Shanka iD, Chavdar S Pavlov iD, Taisiia A Turankova iD, Temesgen Tesfaye Ajabo iD, Leul Mekonnen Nigatu iD, Biniyam Esayas Dana iD

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/1662756 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BioMed Research International, online erschienen am 11.04.2026. Verfasst von Nebyu Yonas Shanka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Therapy, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia, mma.ru. Hauptthemen laut MEDLINE: Hypertension, Portal, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinically significant portal hypertension (CSPH) is a major determinant of adverse outcomes in metabolic dysfunction–associated steatotic liver disease (MASLD), but reliable noninvasive identification remains challenging. We evaluated whether routinely available ultrasound and clinical variables could help identify CSPH in adults with MASLD.

Methods

We performed a retrospective cohort study of adults with MASLD who underwent HVPG measurement at a tertiary referral centre. Routinely available demographic, laboratory, routine ultrasound and liver stiffness variables were evaluated using logistic regression and internally validated machine learning models to identify CSPH, defined as HVPG ≥ 10 mmHg.

Results

Among 218 adults with MASLD, 44 (20.2%) had CSPH. Compared with patients without CSPH, those with CSPH showed less favourable noninvasive profiles, particularly in ultrasound‐ and stiffness‐based measures (liver stiffness: 9.2 vs. 7.8 kPa; spleen length: 119.3 vs. 115.0 mm), whereas most routine biochemical markers were broadly similar between groups. Overall predictive performance was modest across all evaluated models; random forest achieved the highest discrimination (AUC = 0.67), followed by SVM (AUC = 0.65) and logistic regression (AUC = 0.604). In multivariable analysis, portal vein calibre (OR = 1.60) and liver stiffness (OR = 1.134) showed the strongest independent associations with CSPH, although overall predictive accuracy remained limited.

Conclusions

In adults with MASLD, routinely available ultrasound and clinical variables showed only modest ability to identify CSPH. Although some noninvasive markers were independently associated with CSPH, model performance was insufficient for stand‐alone clinical triage. These findings support further refinement of MASLD‐specific noninvasive prediction strategies rather than immediate clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PortalFatty LiverHumansFemaleRetrospective StudiesUltrasonographyMiddle AgedMaleLiverMachine LearningAdultPortal VeinAgedLogistic Models

Stichwörter der Autor:innen

abdominal ultrasoundclinically significant portal hypertension (CSPH)hepatic venous pressure gradient (HVPG)liver stiffnessmachine learningmetabolic dysfunction–associated steatotic liver disease (MASLD)noninvasive risk stratificationplatelet countportal vein diameterrisk prediction

Autor:innen und Institutionen

  • Department of Therapy, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia, mma.ru.
  • Department of Internal Medicine, Wolaita Sodo University Comprehensive Specialised Hospital, Wolaita Sodo, Ethiopia.
  • Department of Hepatology and Gastroenterology, Botkin Moscow City Clinical Hospital, Moscow, Russia.
  • Department of Public Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia, mma.ru.
  • Washington University in St. Louis, St. Louis, Missouri, USA, wustl.edu.

ORCID-Profile: Nebyu Yonas Shanka, Chavdar S Pavlov, Taisiia A Turankova, Temesgen Tesfaye Ajabo, Leul Mekonnen Nigatu, Biniyam Esayas Dana

Zitieren

APA

Shanka, N. Y., Pavlov, C. S., Turankova, T. A., Ajabo, T. T., Nigatu, L. M., & Dana, B. E. (2026). Predicting Clinically Significant Portal Hypertension in MASLD Using Routine Ultrasound and Clinical Data: A Retrospective Cohort Study. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/1662756

Vancouver

Shanka NY, Pavlov CS, Turankova TA, Ajabo TT, Nigatu LM, Dana BE. Predicting Clinically Significant Portal Hypertension in MASLD Using Routine Ultrasound and Clinical Data: A Retrospective Cohort Study. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/1662756

BibTeX
@article{Shanka2026,
  author = {Shanka, Nebyu Yonas and Pavlov, Chavdar S and Turankova, Taisiia A and Ajabo, Temesgen Tesfaye and Nigatu, Leul Mekonnen and Dana, Biniyam Esayas},
  title = {Predicting Clinically Significant Portal Hypertension in MASLD Using Routine Ultrasound and Clinical Data: A Retrospective Cohort Study},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/1662756}
}
Kostenlos starten →